Results 131 to 140 of about 2,081,679 (301)

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf   +10 more
wiley   +1 more source

Toxic shock syndrome other than Streptococcal: (Week 28) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 15, 2023

Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Heart failure medication to prevent cancer therapy–related cardiac dysfunction: A narrative review

British Journal of Pharmacology, EarlyView.
Advances in oncological therapies have improved cancer survival but also have increased the clinical incidence of cancer therapy–related cardiac dysfunction (CTRCD), a spectrum of conditions ranging from subclinical biomarker or strain abnormalities to progressive heart failure and cardiogenic shock.
Fabian Voß, Paul Goerke, Malte Kelm, Amin Polzin   +3 more
wiley   +1 more source

Toxic shock syndrome other than Streptococcal: (Week 38) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 23, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally

core  

Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation

British Journal of Pharmacology, EarlyView.
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral, Nicholas Monaco, Daniel I. Brierley, Monica Imbernon   +3 more
wiley   +1 more source

Toxic shock syndrome other than Streptococcal: (Week 45) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 11, 2023

Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Histone deacetylase inhibitors as venetoclax‐sensitising partners in acute myeloid leukaemia: Mechanisms, pharmacology and translational perspectives

British Journal of Pharmacology, EarlyView.
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley   +1 more source

Toxic shock syndrome other than Streptococcal: (Week 50) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 16, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally

core  

Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Premature ovarian insufficiency (POI), the loss of ovarian function before age 40, increases the risk of cardiovascular disease, low bone mineral density, dementia and psychological distress. Lifestyle interventions reduce chronic disease risk in other populations and, with hormone therapy, may improve health outcomes in POI.
Ladan Yeganeh, Nathalie Vermeulen, Carolyn Ee, Helena Teede, Amanda J. Vincent   +4 more
wiley   +1 more source

Streptococcal Toxic Shock Syndrome: Persistent Diagnostic and Therapeutic Challenges. [PDF]

Cureus
Šimonová J, Šimon R, Pirníková I, Andrejkovič M, Popaďák P.   +4 more
europepmc   +1 more source